Caffeine prevents cataracts

Article

Consumption of caffeine prevents against the formation of cataracts due to ultraviolet (UV) light radiation, according to study results published in the October edition of the Journal of Ocular Pharmacology and Therapeutics.

Consumption of caffeine prevents against the formation of cataracts due to ultraviolet (UV) light radiation, according to study results published in the October edition of the Journal of Ocular Pharmacology and Therapeutics.

Shambu D. Varma of the departments of biochemistry and ophthalmology and visual sciences at the University of Maryland School of Medicine, Baltimore, Maryland, US and colleagues examined the effects of xanthine-based alkaloids, including caffeine, on in vitro mouse lens cultures.

The team found that exposure of the lenses to UV radiation at 302 nm decreased active transportation of the ion 86Rb+ (a K+ analogue), and also decreased levels of adenosine triphosphate and glutathione. Introducing caffeine into the cultures insulated the lenses against this physiological damage.

Thus the team concluded that caffeine does indeed prevent the lens degradation and cataract formation that is caused by exposure to UV light.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.